Author Archives | Simplyjo
Simplyjo - who has written 81 posts on FavStocks.
I have done by Post Graduation in Tourism from College of Vocational Studies apart from a full time MBA degree in Finance.I have worked with several reputed companies including IBM, MakeMyTrip and Habitat World.
I love to read, write and travel.
Currently, I am a SAHM ,earning a living off the stock market and making a killing with forex trades. I am sharing my knowledge so as to help others learn and expand their horizon.
GE Lands New Major Gas Project (NYSE:GE)
General Electric Company (NYSE:GE) is really having a good week with favorable news of company’s growth from all around.
Continue reading...GE’s Healthymagination (NYSE:GE)
23 October 2009
Comments Off
In one of the surprising news on Thursday, General Electric Company (NYSE:GE) has decided to launch a new US$250 million venture fund as an investment in new life sciences technologies along with Eli Lilly that will work on new cancer research.
Continue reading...Amgen’s Plan for Denosumab (NASDAQ:AMGN)
23 October 2009
Comments Off
On Thursday, Amgen, Inc. (NASDAQ:AMGN) have opened up about the new plans about how the company will actually handle the request for the new information asked by the Food and Drug Administration panel.
Continue reading...Antigenics’ shares slide down (NASDAQ:AGEN)
22 October 2009
Comments Off
On Wednesday morning, Antigenics had a fresh round of bad news from European regulators announcing that they have rejected their new kidney cancer vaccine called Oncophage.
Continue reading...Pfizer Wyeth Collaboration Problems (NYSE:PFE)
21 October 2009
Comments Off
From the very first day when Pfizer and Wyeth announced their merger agreement, there has been a lot of commotion in the stock market at the same time concerns about how both this pharmaceutical giants will combine their teams of scientists and others employees working in the R&D unit.
Continue reading...Pfizer Management Blamed (NYSE:PFE)
17 October 2009
Comments Off
A subsidiary of Pfizer, Pharmacia and Upjohn has been sentenced after pleading guilty to illegally promoting Bextra pain killers.
Continue reading...Pfizer Wyeth acquisition could affect jobs (NYSE:PFE)
16 October 2009
Comments Off
On a Thursday morning, Pfizer announced that they have successfully completed the acquisition of Wyeth following the receipt of regulatory approval from all the government authorities required by the merger agreement and approval by Wyeth shareholders.
Continue reading...Protalix Top Line Results (AMEX:PLX)
16 October 2009
Comments Off
On Thursday, shares of Protalix BioTherapeutics moved upwards after they announced the positive results from their Phase 3 clinical trial of UPLYSO drug for the treatment of Gaucher disease.
Continue reading...Amgen Facing Delays (NASDAQ:AMGN)
16 October 2009
Comments Off
Amgen Inc is not really sure if they will have to wait or not but many of the biotech investors have speculated that Amgen’s Bone drug may have to face significant delays in the final decision by the Food and Drug Administration.
Continue reading...Acorda Gains Momentum (NASDAQ:ACOR)
16 October 2009
Comments Off
Acorda Therapeutics had a not so very good Wednesday morning with NASDAQ halting their trading on the stock market as the review by the Food and Drug Administration panel was due.
Continue reading...
23 October 2009
Comments Off